Edesa Biotech, Inc.EDSANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank14
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-7.32M
Near historical average
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-6.84M
Historical baseline
PeriodValueYoY Change
2025$-7.32M-49.7%
2024$-4.89M+26.3%
2023$-6.64M+46.0%
2022$-12.28M+10.1%
2021$-13.66M-174.0%
2020$-4.99M-2.9%
2019$-4.85M-5.0%
2018$-4.62M+1.8%
2017$-4.70M-4.3%
2016$-4.51M-